Instituto de Investigación Sanitaria de Navarra-ko ikertzaileekin lankidetzan egindako argitalpenak (21)

2024

  1. Mucus-penetrating and permeation enhancer albumin-based nanoparticles for oral delivery of macromolecules: Application to bevacizumab

    Drug Delivery and Translational Research, Vol. 14, Núm. 5, pp. 1189-1205

  2. Targeting and activation of macrophages in leishmaniasis. A focus on iron oxide nanoparticles

    Frontiers in Immunology, Vol. 15

  3. Zein nanoparticles extend lifespan in C. elegans and SAMP8 mice

    International Journal of Pharmaceutics, Vol. 666

2023

  1. 3D printing of microencapsulated Lactobacillus rhamnosus for oral delivery

    International Journal of Pharmaceutics, Vol. 641

  2. Encapsulation of Lactobacillus plantarum in casein-chitosan microparticles facilitates the arrival to the colon and develops an immunomodulatory effect

    Food Hydrocolloids, Vol. 136

  3. Zein-based nanospheres and nanocapsules for the encapsulation and oral delivery of quercetin

    International Journal of Pharmaceutics, Vol. 643

2022

  1. Effect of topical berberine in murine cutaneous leishmaniasis lesions

    Journal of Antimicrobial Chemotherapy, Vol. 77, Núm. 4, pp. 1072-1081

2021

  1. 3,5-Dimethyl-4-isoxazoyl selenocyanate as promising agent for the treatment of Leishmania infantum-infected mice

    Acta Tropica, Vol. 215

  2. Changes in the nanoparticle uptake and distribution caused by an intramacrophagic parasitic infection

    Nanoscale, Vol. 13, Núm. 41, pp. 17486-17503

  3. In vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions

    Acta Pharmaceutica Sinica B, Vol. 11, Núm. 4, pp. 989-1002

  4. Oral Efficacy of a Diselenide Compound Loaded in Nanostructured Lipid Carriers in a Murine Model of Visceral Leishmaniasis

    ACS Infectious Diseases, Vol. 7, Núm. 12, pp. 3197-3209

  5. Zein-based nanocarriers for the oral delivery of insulin. In vivo evaluation in Caenorhabditis elegans

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 647-658

2020

  1. Berberine-loaded liposomes for the treatment of leishmania infantum-infected balb/c mice

    Pharmaceutics, Vol. 12, Núm. 9, pp. 1-18

2019

  1. Evaluation of skin permeation and retention of topical dapsone in murine cutaneous leishmaniasis lesions

    Pharmaceutics, Vol. 11, Núm. 11

2018

  1. Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions

    Journal of Dermatological Science, Vol. 92, Núm. 1, pp. 78-88

2017

  1. A combination of nanosystems for the delivery of cancer chemoimmunotherapeutic combinations: 1-Methyltryptophan nanocrystals and paclitaxel nanoparticles

    Pharmacological Research, Vol. 126, pp. 77-83

  2. Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery

    International Journal of Pharmaceutics, Vol. 517, Núm. 1-2, pp. 67-79

  3. Genotoxic evaluation of poly(anhydride) nanoparticles in the gastrointestinal tract of mice

    International Journal of Pharmaceutics, Vol. 530, Núm. 1-2, pp. 187-194

  4. In vitro evaluation of the genotoxicity of poly(anhydride) nanoparticles designed for oral drug delivery

    International Journal of Pharmaceutics, Vol. 523, Núm. 1, pp. 418-426

  5. Skin vaccination using microneedles coated with a plasmid DNA cocktail encoding nucleosomal histones of Leishmania spp.

    International Journal of Pharmaceutics, Vol. 533, Núm. 1, pp. 236-244